CVS HEALTH Corp (CVS) Stock Price, Financials & Summary

Price chart

Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18

Key dataSep 18, 2026

Open$90.09

From 52W high−19.67%

Volume21.66M

Market cap$113.62B

P/E (TTM)23.2x

P/S (TTM)0.3x

Div yield2.99%

Key dataSep 18, 2026

Open

$90.09

From 52W high

−19.67%

Volume

21.66M

Market cap

$113.62B

ValuationView details →

P/E (Fwd)

10.9x

EV/EBITDA

13.1x

P/E (TTM)

23.2x

RSI (14)

28.8

MomentumView details →

1D Return

−1.58%

YTD Return

+11.38%

SummaryUpdated Jun 1, 2026

CVS Health Corporation (NYSE:CVS) is one of America's largest integrated healthcare companies, founded in 1963 as Consumer Value Stores in Lowell, Massachusetts. Originally a small chain of health and beauty stores, CVS has transformed through decades of strategic acquisitions and organic growth into a comprehensive healthcare ecosystem. The company operates through three primary business segments: Healthcare Benefits (including the Aetna insurance business acquired in 2018), Health Services (pharmacy benefit management and specialty pharmacy services), and Pharmacy and Consumer Wellness (retail pharmacies and MinuteClinic walk-in medical facilities). Today, CVS serves over 100 million customers annually through approximately 9,900 retail locations and has become a Fortune 4 company with annual revenues exceeding $370 billion.

Ask drillr about CVS HEALTH Corp →

ValuationView details →

P/E (Fwd)

10.9x

P/E (TTM)

23.2x

EV/EBITDA

13.1x

EV/Sales

0.4x

P/S (TTM)

0.3x

P/B (TTM)

1.4x

ProfitabilityView details →

Gross Margin

14.15%

Net Margin

1.18%

EBITDA Margin

3.23%

ROE (TTM)

6.16%

ROA (TTM)

1.93%

Asset Turnover

1.64x

GrowthView details →

Revenue YoY

+7.36%

EPS YoY

+6.42%

FCF YoY

+145.98%

Revenue CAGR 3Y

+7.63%

EPS CAGR 3Y

−24.78%

EBITDA YoY

−5.44%

MomentumView details →

1D Return

−1.58%

YTD Return

+11.38%

1Y Return

+17.99%

RSI (14)

28.8

vs 50D SMA

−10.66%

vs 200D SMA

+1.32%

Capital & dividendView details →

Debt/Equity

0.96x

Current Ratio

0.87x

Quick Ratio

0.66x

Div Yield

2.99%

Div Rate

$2.66

Div Growth 1Y

+0.00%

EarningsView details →

EPS (Actual)

$2.58

EPS Surprise

37.97%

Beats (12Q)

11/12

Next Q EPS Est

$1.63

Avg Surprise (4Q)

24.15%

Rev Surprise

6.07%

Financials snapshotView financials →

Revenue (TTM)

415.09B

Net Income (TTM)

4.91B

Op. CF (TTM)

14.78B

Next earningsNov 4, 2026 →

Latest newsMore news →

Ascension agreed to sell its ownership stake in Arizona Medicaid insurer Mercy Care to CVS Health-owned Aetna, pending regulatory approval.2d ago

Omnicare reached a $440 million settlement with the U.S. Department of Justice to resolve an improper billing case, requiring CVS to pay $130 million upfront and cover the remaining $310 million if Omnicare fails to pay by March 2028.2d ago

Similar companies

Elevance Health Inc.ELV Cigna CorporationCI Humana Inc.HUM UnitedHealth Group IncorporatedUNH Centene CorporationCNC Molina Healthcare, Inc.MOH Find similar companies →

Latest newsMore news →

Ascension agreed to sell its ownership stake in Arizona Medicaid insurer Mercy Care to CVS Health-owned Aetna, pending regulatory approval.2d ago Omnicare reached a $440 million settlement with the U.S. Department of Justice to resolve an improper billing case, requiring CVS to pay $130 million upfront and cover the remaining $310 million if Omnicare fails to pay by March 2028.2d ago CVS Omnicare, the long-term care pharmacy subsidiary of CVS Health, received court approval from Judge Stacey G. C. Jernigan of the U.S. Bankruptcy Court for the Northern District of Texas for its Chapter 11 wind-down bankruptcy plan after selling its business operations for $250 million.2d ago